FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.4  |  FHIR Version n/a  User: [n/a]

385114002: Prolonged-release transdermal patch (dose form)

Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jan 2018. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
3634738017 Prolonged-release transdermal patch (dose form) en Fully specified name Active Entire term case insensitive SNOMED CT core module
3634739013 Prolonged-release transdermal patch en Synonym Active Entire term case insensitive SNOMED CT core module
106069801000001110 Transdermal patch en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom Edition module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Prolonged-release transdermal patch Is a Cutaneous AND/OR transdermal dosage form false Inferred relationship Existential restriction modifier
Prolonged-release transdermal patch Is a Drug patch false Inferred relationship Existential restriction modifier
Prolonged-release transdermal patch Has dose form intended site Transdermal true Inferred relationship Existential restriction modifier
Prolonged-release transdermal patch Is a Transdermal dose form true Inferred relationship Existential restriction modifier
Prolonged-release transdermal patch Has dose form administration method Apply true Inferred relationship Existential restriction modifier
Prolonged-release transdermal patch Has dose form transformation No transformation true Inferred relationship Existential restriction modifier
Prolonged-release transdermal patch Has dose form release characteristic Prolonged-release true Inferred relationship Existential restriction modifier
Prolonged-release transdermal patch Has basic dose form Patch true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Rivastigmine 9.5mg/24hours transdermal patches (Alliance Healthcare (Distribution) Ltd) Has dispensed dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Voleze 13.3mg/24hours transdermal patches (Focus Pharmaceuticals Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Rivastigmine 9.5mg/24hours transdermal patches (Alliance Healthcare (Distribution) Ltd) 30 patch Has dispensed dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Voleze 13.3mg/24hours transdermal patches (Focus Pharmaceuticals Ltd) 30 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Bupeaze 35micrograms/hour transdermal patches (Dr Reddy's Laboratories (UK) Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Bupeaze 52.5micrograms/hour transdermal patches (Dr Reddy's Laboratories (UK) Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Bupeaze 70micrograms/hour transdermal patches (Dr Reddy's Laboratories (UK) Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Bupeaze 35micrograms/hour transdermal patches (Dr Reddy's Laboratories (UK) Ltd) 4 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Bupeaze 52.5micrograms/hour transdermal patches (Dr Reddy's Laboratories (UK) Ltd) 4 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Bupeaze 70micrograms/hour transdermal patches (Dr Reddy's Laboratories (UK) Ltd) 4 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Victanyl 12micrograms/hour transdermal patches (Accord Healthcare Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Victanyl 12micrograms/hour transdermal patches (Accord Healthcare Ltd) 5 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Prenotrix 35micrograms/hour transdermal patches (Genesis Pharmaceuticals Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Prenotrix 35micrograms/hour transdermal patches (Genesis Pharmaceuticals Ltd) 4 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Testosterone 2.5mg/24hours transdermal patches (Special Order) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Testosterone 2.5mg/24hours transdermal patches 1 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Testosterone 2.5mg/24hours transdermal patches (Special Order) 1 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Testosterone 300micrograms/24hours transdermal patches (J M McGill Ltd) Has dispensed dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Prenotrix 52.5micrograms/hour transdermal patches (Genesis Pharmaceuticals Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Prenotrix 70micrograms/hour transdermal patches (Genesis Pharmaceuticals Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Testosterone 300micrograms/24hours transdermal patches (J M McGill Ltd) 8 patch Has dispensed dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Prenotrix 52.5micrograms/hour transdermal patches (Genesis Pharmaceuticals Ltd) 4 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Prenotrix 70micrograms/hour transdermal patches (Genesis Pharmaceuticals Ltd) 4 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Reletrans 5micrograms/hour transdermal patches (Sandoz Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Reletrans 10micrograms/hour transdermal patches (Sandoz Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Reletrans 15micrograms/hour transdermal patches (Sandoz Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Reletrans 20micrograms/hour transdermal patches (Sandoz Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Panitaz 5micrograms/hour transdermal patches (Dr Reddy's Laboratories (UK) Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Panitaz 10micrograms/hour transdermal patches (Dr Reddy's Laboratories (UK) Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Panitaz 20micrograms/hour transdermal patches (Dr Reddy's Laboratories (UK) Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Reletrans 5micrograms/hour transdermal patches (Sandoz Ltd) 4 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Reletrans 10micrograms/hour transdermal patches (Sandoz Ltd) 4 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Reletrans 15micrograms/hour transdermal patches (Sandoz Ltd) 4 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Reletrans 20micrograms/hour transdermal patches (Sandoz Ltd) 4 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Panitaz 5micrograms/hour transdermal patches (Dr Reddy's Laboratories (UK) Ltd) 4 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Panitaz 10micrograms/hour transdermal patches (Dr Reddy's Laboratories (UK) Ltd) 4 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Panitaz 20micrograms/hour transdermal patches (Dr Reddy's Laboratories (UK) Ltd) 4 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Buprenorphine 5micrograms/hour transdermal patches (A A H Pharmaceuticals Ltd) Has dispensed dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Buprenorphine 10micrograms/hour transdermal patches (A A H Pharmaceuticals Ltd) Has dispensed dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Buprenorphine 20micrograms/hour transdermal patches (A A H Pharmaceuticals Ltd) Has dispensed dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Buprenorphine 5micrograms/hour transdermal patches (A A H Pharmaceuticals Ltd) 4 patch Has dispensed dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Buprenorphine 10micrograms/hour transdermal patches (A A H Pharmaceuticals Ltd) 4 patch Has dispensed dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Buprenorphine 20micrograms/hour transdermal patches (A A H Pharmaceuticals Ltd) 4 patch Has dispensed dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Sevodyne 5micrograms/hour transdermal patches (Aspire Pharma Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Sevodyne 10micrograms/hour transdermal patches (Aspire Pharma Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Sevodyne 20micrograms/hour transdermal patches (Aspire Pharma Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Sevodyne 5micrograms/hour transdermal patches (Aspire Pharma Ltd) 4 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Sevodyne 10micrograms/hour transdermal patches (Aspire Pharma Ltd) 4 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Sevodyne 20micrograms/hour transdermal patches (Aspire Pharma Ltd) 4 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Buplast 52.5micrograms/hour transdermal patches (Viatris UK Healthcare Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Buplast 35micrograms/hour transdermal patches (Viatris UK Healthcare Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Buplast 70micrograms/hour transdermal patches (Viatris UK Healthcare Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Buplast 52.5micrograms/hour transdermal patches (Viatris UK Healthcare Ltd) 4 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Buplast 35micrograms/hour transdermal patches (Viatris UK Healthcare Ltd) 4 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Buplast 70micrograms/hour transdermal patches (Viatris UK Healthcare Ltd) 4 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Norelgestromin 150micrograms/24hours / Ethinylestradiol 20micrograms/24hours patches Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Clonidine 200micrograms/24hours patches Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Testosterone 300micrograms/24hours patches Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Oxybutynin 3.9mg/24hours patches Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Diclofenac 1% patches Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Buprenorphine 5micrograms/hour patches Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Buprenorphine 10micrograms/hour patches Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Buprenorphine 20micrograms/hour patches Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Fentanyl 12micrograms/hour patches Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Rotigotine 8mg/24hours patches Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Clonidine 100micrograms/24hours patches Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Clonidine 300micrograms/24hours patches Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Rivastigmine 4.6mg/24hours transdermal patches Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Rivastigmine 9.5mg/24hours transdermal patches Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Testosterone 2.4mg/24hours transdermal patches Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Nicotine 25mg/16hours transdermal patches Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Generic Jointace deep aroma transdermal patches Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Generic GlucOsamine Gel Patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Rotigotine 3mg/24hours transdermal patches Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Rotigotine 1mg/24hours transdermal patches Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Rivastigmine 13.3mg/24hours transdermal patches Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Fentanyl 37.5microgram/hour transdermal patches Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Buprenorphine 15micrograms/hour transdermal patches Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Clonidine 100micrograms/24hours transdermal patches (Special Order) Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
GlucOsamine Gel Patch (William Ransom & Son Plc) Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Exelon 4.6mg/24hours transdermal patches (Mawdsley-Brooks & Company Ltd) Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Intrinsa 300micrograms/24hours transdermal patches (Necessity Supplies Ltd) Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Intrinsa 300micrograms/24hours transdermal patches (Doncaster Pharmaceuticals Ltd) Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Neupro 8mg/24hours transdermal patches (Lexon (UK) Ltd) Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Exelon 13.3 mg/24hours transdermal patches (Novartis Pharmaceuticals UK Ltd) Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Rivastigmine 9.5mg/24hours transdermal patches (A A H Pharmaceuticals Ltd) Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Opiodur 12micrograms/hour transdermal patches (Pfizer Ltd) Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Rivastigmine 13.3mg/24hours transdermal patches (A A H Pharmaceuticals Ltd) Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Butec 20micrograms/hour transdermal patches (Qdem Pharmaceuticals Ltd) Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Butec 5micrograms/hour transdermal patches (Qdem Pharmaceuticals Ltd) Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Rivastigmine 9.5mg/24hours transdermal patches (Alliance Healthcare (Distribution) Ltd) Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Panitaz 20micrograms/hour transdermal patches (Dr Reddy's Laboratories (UK) Ltd) Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Intrinsa 300micrograms/24hours transdermal patches (Mawdsley-Brooks & Company Ltd) Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Neupro 8mg/24hours transdermal patches (Mawdsley-Brooks & Company Ltd) Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Neupro 8mg/24hours transdermal patches (Sigma Pharmaceuticals Plc) Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Durogesic DTrans 12 transdermal patches (Doncaster Pharmaceuticals Ltd) Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Exelon 9.5mg/24hours transdermal patches (Doncaster Pharmaceuticals Ltd) Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Durogesic DTrans 12 transdermal patches (Lexon (UK) Ltd) Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Rivatev 4.6mg/24hours transdermal patches (Teva UK Ltd) Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Rivastigmine 9.5mg/24hours transdermal patches (Actavis UK Ltd) Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Eluden 4.6mg/24hours transdermal patches (Viatris UK Healthcare Ltd) Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier

Start Previous Page 18 of 21 Next End

This concept is not in any reference sets

Back to Start